Zenas BioPharma, Inc. (ZBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -75.2M | -52.41M | -41.13M | -41.74M | -37.05M | -38.55M | -31.06M | -30.96M | -19.1M | -15.4M | 31.85M |
| Operating CF Margin % | - | - | - | - | -370.51% | -771.08% | - | - | - | - | 63.69% |
| Operating CF Growth % | -102.95% | -35.95% | -32.41% | -34.83% | -93.96% | -150.35% | -197.53% | - | - | - | - |
| Net Income | -80.99M | -240.44M | -51.5M | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M |
| Depreciation & Amortization | -104K | -29K | 11K | -923K | 23K | 33K | 36K | 35K | 33K | 30K | 26K |
| Stock-Based Compensation | 9.2M | 7.58M | 7.34M | 6.04M | 5.39M | 5.5M | 2.84M | 1.54M | 947K | 1.14M | 1M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 6.56M | 172.16M | 6.69M | 200K | -29K | -344K | 125K | 291K | 853K | 455K | 173K |
| Working Capital Changes | -9.86M | 8.31M | -3.66M | 5.16M | -8.86M | 8.87M | 4.54M | 5.16M | 6.87M | 7.57M | -4.96M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.79M | 1.12M | -1.95M | -12.09M | 2.88M | 5.42M | 3.39M | -480K | 3.41M | 3.12M | -1.34M |
| Cash from Investing | 31.61M | -93.36M | 40.04M | -112.29M | -86.27M | -3.73M | -26.76M | -35K | -22K | -17K | 0 |
| Capital Expenditures | -2K | 0 | 0 | 0 | -18K | -74K | 0 | -35K | -22K | -17K | 0 |
| CapEx % of Revenue | - | - | - | - | 0.18% | 1.48% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -30M | -5M | 0 | 0 | 0 | -26.76M | 0 | 0 | 0 | 0 |
| Cash from Financing | 433.48M | 140.84M | 72.62M | 1.72M | 99K | 1.85M | 233.98M | 177.74M | -614K | 50K | 20M |
| Debt Issued (Net) | 267.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M |
| Equity Issued (Net) | 166.45M | 150.18M | 940K | 1.72M | 99K | 6.25M | 234.42M | 178.5M | 42K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -9.34M | 71.68M | 0 | 0 | -4.4M | -439K | -766K | -656K | 50K | 0 |
| Net Change in Cash | 389.58M | -4.92M | 71.56M | -152.55M | -123.28M | -40.3M | 176.11M | 146.78M | -19.7M | -15.45M | 51.85M |
| Free Cash Flow | -75.2M | -52.41M | -41.13M | -41.74M | -37.07M | -38.63M | -31.06M | -30.99M | -19.12M | -15.42M | 31.85M |
| FCF Margin % | - | - | - | - | -370.69% | -772.56% | - | - | - | - | 63.69% |
| FCF Growth % | -102.86% | -35.69% | -32.41% | -34.68% | -93.84% | -150.55% | -197.53% | - | - | - | - |
| FCF per Share | -1.35 | -1.13 | -0.98 | -1.00 | -0.89 | -0.92 | -0.74 | -0.81 | -0.50 | -0.40 | 0.76 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.22x | 0.80x | 0.80x | 1.10x | 0.73x | 0.80x | 0.82x | 0.69x | 0.63x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |